SDI Threatens More Than Academic Freedom

I take exception to the article by Jack Ruina (The Scientist, February 23, 1987, p. 12), which contends that there should be no organized pressure within universities against accepting SDI research funding. He discusses the political nature of this pressure but neglects to add that there is political pressure from the other side bearing on funding allotments and the funding process. Funds for research do not come out of a vacuum, but are the result of political processes within an administration

Written byPhilip Siekevitz
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Funds for research do not come out of a vacuum, but are the result of political processes within an administration and Congress; SDI research funding is such an example. My feeling is that scientists can resist the pressure and should be free to communicate their resistance to other scientists. We are under no obligation to accept political money just because it comes as manna from heaven.

Ruina thinks that organized resistance on campuses is "inimical to the fragile academic enterprise," and I agree. But I would also add that the consequences of operational SDI are so horrendous for the fragility of our Earth that academic integrity pales before a nuclear arms race becoming out of control, possibly ending in the obliteration of universities.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies